A controlled in-patient pilot study with the antidepressant mebanazine, a mono amine oxidase inhibitor of the hydrazine group. I.
D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood / Q000652:urine; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use / Q000633:toxicity; D007022:Hypotension / Q000139:chemically induced; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use / Q000633:toxicity; D010919:Placebos / Q000627:therapeutic use
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D001219:Aspartate Aminotransferases; D002746:Chlorpromazine